Skip to Content

Symtuza Prices, Coupons and Patient Assistance Programs

Symtuza (cobicistat/darunavir/emtricitabine/tenofovir alafenamide) is a member of the antiviral combinations drug class and is commonly used for HIV Infection.

Symtuza Prices

The cost for Symtuza oral tablet (150 mg-800 mg-200 mg-10 mg) is around $4,253 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Symtuza is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Symtuza availability.

This Symtuza price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Oral Tablet

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Symtuza Coupons and Rebates

Symtuza offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Symtuza Janssen CarePath Savings Program: Most eligible commercially insured patients may pay $0 per fill on out-of-pocket costs with savings of up to $12,500 per calendar year; for additional assistance contact the program at 866-836-0114.

Applies to:
Symtuza
Number of uses:
12 times within calendar year

More information please phone: 866-836-0114 Visit Website

Symtuza Janssen CarePath Savings Program Rebate: Eligible commercially insured patients may submit a rebate request if the pharmacy does not accept the Savings Card; for additional assistance contact the program at 866-836-0114.

Applies to:
Symtuza
Number of uses:
One rebate per prescription fill

More information please phone: 866-836-0114 Visit Website

Patient Assistance Programs for Symtuza

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Johnson & Johnson Patient Assistance Foundation, Inc. Hospital Access Patient Assistance Program

Elligibility requirements:
  1. Contact program for details.
  2. Not applicable
  3. Not applicable
  4. Must be residing in the US or US territory
  5. This program allows eligible hospitals to receive free medications to give to qualified outpatients directly. Contact the program for more details (1-800-652-6227). The hospital access application is only available via the online portal.
Applicable drugs:
  • Symtuza (darunavir-cobicistat-emtricitabine-tenofovir alafenamide) Tablet

More information please phone: 800-652-6227 Visit Website

Provider: Johnson & Johnson Patient Assistance Foundation, Inc. Patient Assistance Program

Elligibility requirements:
  1. Must have no prescription coverage for needed medication
  2. Varies. **See below for details
  3. Medication must be for outpatient use only
  4. The patient must also be permanently residing in the US or US territories.
  5. *Some Medicare Part D patients who cannot afford their medicines, and who meet certain financial criteria, may also be eligible for assistance. Please Contact the program for more information (1-800-652-6227). **Please call 1-800-652-6227 or visit Program website for specific FPL income requirements.
Applicable drugs:
  • Symtuza (darunavir-cobicistat-emtricitabine-tenofovir alafenamide) Tablet

More information please phone: 800-652-6227 Visit Website

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Symtuza (darunavir-cobicistat-emtricitabine-tenofovir alafenamide) Tablet

More information please phone: 866-316-7263 Visit Website

Provider: Good Days Program

Elligibility requirements:
  1. Must have insurance
  2. At or below 500% of FPL
  3. FDA-approved diagnosis
  4. The patient must also be a US resident with a Social Security Number.
  5. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
Applicable drugs:
  • Symtuza (darunavir-cobicistat-emtricitabine-tenofovir alafenamide) Tablet

More information please phone: 877-968-7233 Visit Website

Provider: HarborPath ADAP Waiting List Program

Elligibility requirements:
  1. Must be uninsured
  2. Determined case by case
  3. Medically appropriate condition/diagnosis
  4. The patient must also be a US resident.
  5. Resources for HEALTHCARE PROFESSIONALS ONLY. Patients are eligible for the HarborPath ADAP Waiting List Program if they: Meet eligibility for the ADAP Waiting List Program in their state of residency; and have a confirmation letter from their state ADAP indicating patient is on the ADAP waiting list. Typical eligibility requirements do not apply to the ADAP Waiting List Program.
Applicable drugs:
  • Symtuza (darunavir-cobicistat-emtricitabine-tenofovir alafenamide) Tablet

More information please phone: 855-300-8916 Visit Website

Provider: My Janssen CarePath

Elligibility requirements:
  1. Determined case by case
  2. Based on FPL
  3. Must be used for on-label diagnosis
  4. The patient must be a US citizen or legal resident.
  5. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Symtuza (darunavir-cobicistat-emtricitabine-tenofovir alafenamide) Tablet

More information please phone: 866-228-3546   or 877-227-3728   Visit Website

More about Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide)

Consumer resources

Professional resources

Related treatment guides